Peter Menziuso
Fortuna: 2 M $ al 31/05/2026
Fortuna: 2 M $ al 31/05/2026
Peter A. Menziuso currently holds the position of Group Chairman at Johnson & Johnson Vision Care, Inc. He is also a Director at the Ophthalmology Foundation since 2023.
Additionally, he is set to be Executive VP & President-BD Interventional at Becton, Dickinson & Co. starting in 2026.
Mr. Menziuso completed undergraduate education at the University of Scranton.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 01/06/2026 | 14.258 ( 0,01 % ) | 2 M $ | 31/05/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| BECTON, DICKINSON AND COMPANY | Corporate Officer/Principal | 01/06/2026 |
Johnson & Johnson Vision Care, Inc.
Johnson & Johnson Vision Care, Inc. Electronic ComponentsElectronic Technology Manufactures and markets vision care products | Presidente | - |
Ophthalmology Foundation | Director/Miembro de la Junta | 29/06/2023 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 4 |
|---|---|
Becton, Dickinson & Co.
Becton, Dickinson & Co. Medical SpecialtiesHealth Technology Manufactures and sells medical supplies, devices, laboratory equipment & diagnostic products | Health Technology |
University of Scranton
University of Scranton Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Johnson & Johnson Vision Care, Inc.
Johnson & Johnson Vision Care, Inc. Electronic ComponentsElectronic Technology Manufactures and markets vision care products | Electronic Technology |
Ophthalmology Foundation | Commercial Services |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.